Cramer's Morning Take: Eli Lilly & Novo Nordisk 1/24/25
Squawk on the Street
00:00
Comparing Weight Loss Drug Innovations: Eli Lilly vs. Novo Nordisk
This chapter explores the competitive dynamics between Eli Lilly and Novo Nordisk in the weight loss drug market, focusing on Novo's promising clinical trial results for their experimental drug. It compares the efficacy of both companies' drugs while also offering insights into stock performance amid the evolving landscape.
Transcript
Play full episode
